NDC 59368-402 - Ibuprofen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59368-402
- Package NDCs from labels
- 59368-402-01
- Manufacturer
- Praxis, LLC
- Effective date
- 2023-01-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ibuprofen - Praxis, LLC | Praxis, LLC | 2023-01-01 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SODIUM PHENYLACETATE AND SODIUM BENZOATE | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Zydus Pharmaceuticals USA Inc. | 204e84a7-5440-4537-9e40-06eb56c415e9 | 2024-09-30 | Warnings, Adverse reactions | OJ245FE5EU |
| Sodium Phenylacetate and sodium benzoate | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Navinta LLC | fbc7bfe3-6faa-45a3-befb-9ad7963c0571 | 2024-09-30 | Warnings, Adverse reactions | OJ245FE5EU |
| Ibuprofen 200mg | IBUPROFEN 200MG | Allegiant Health | 265e2b47-d14a-45a8-adc0-7214e2057103 | 2024-09-30 | Warnings | WK2XYI10QM |
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BUTYL ACETATE, ETHYL ACETATE, TOLUENE, XYLENE, BISPHENOL A, PETROLEUM, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR | Energique, Inc. | 87c92497-8a51-4977-87fe-e0b4c6bafb19 | 2024-09-27 | Warnings | 6DC9Q167V3 |
| hemorrhoidal maximum strength pain relief | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Kroger Company | 3c8f90e2-fecf-4439-9faa-81a32ffe4753 | 2024-09-26 | Warnings | PDC6A3C0OX |
| equate hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Wal-Mart Stores Inc | 5ccefdbd-bbbe-4cbf-9fdb-3c568643e14d | 2024-09-26 | Warnings | PDC6A3C0OX |
| Dual Action Pain Relief | ACETAMINOPHEN, IBUPROFEN | TARGET CORPORATION | e680652b-30d8-6009-e053-2995a90abe29 | 2024-09-25 | Warnings | WK2XYI10QM |
| Advanced Eye Relief/ Redness Maximum Relief | NAPHAZOLINE HYDROCHLORIDE AND HYPROMELLOSE | Bausch & Lomb Incorporated | 3c11285a-7e86-4b47-b1ee-e7d59858087d | 2024-09-25 | Warnings | 3NXW29V3WO |
| Walgreens Hemorrhoidal Pain Relief | GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25% | Walgreens | e79ed7ae-0d06-2f88-e053-2995a90a1e35 | 2024-09-20 | Warnings | PDC6A3C0OX |
| Soothe | GLYCERIN AND PROPYLENE GLYCOL | Bausch & Lomb Incorporated | fef002ea-c4bd-4486-a42e-1bbd9d73d28d | 2024-09-20 | Warnings | 6DC9Q167V3 PDC6A3C0OX |
| TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 02015040-9b71-4dbe-8f8d-e0d0951e8f93 | 2024-09-19 | Warnings | XF417D3PSL |
| equate ibuprofen | IBUPROFEN | Wal-Mart Stores Inc | 307b0257-d636-416b-828a-f901782e9b10 | 2024-09-13 | Warnings | WK2XYI10QM |
| basic care ibuprofen pm | DIPHENHYDRAMINE CITRATE, IBUPROFEN | Amazon.com Services LLC | 6bd8bad2-4370-4450-822a-9ef50949a8fc | 2024-09-09 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Asclemed USA, Inc. | ca81671d-1ea8-4c67-802f-adb3a2f087cc | 2024-09-08 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Leader Preservative-Free Ultra Lubricating Eye Drops | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Cardinal Health | 2a2aa620-ca63-4698-88fd-fc263b8fa0d1 | 2024-09-07 | Warnings | 6DC9Q167V3 |
| Ibuprofen | IBUPROFEN | NuCare Pharmaceuticals, Inc. | 214e3b3e-87b9-9ff5-e063-6394a90ae96a | 2024-09-04 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | MARKSANS PHARMA LIMITED | e54209c2-f726-440b-ac60-5a72710d2a9b | 2024-08-28 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| IBUPROFEN | IBUPROFEN | TIME CAP LABORATORIES,INC | 82aad715-f652-471b-840c-5151c66e5ade | 2024-08-28 | Warnings | WK2XYI10QM |
| Dual Action | ACETAMINOPHEN, IBUPROFEN | BETTER LIVING BRANDS, LLC | f2c096bb-cfed-bfa4-e053-2995a90af2cb | 2024-08-22 | Warnings | WK2XYI10QM |
| Ibuprofen Minis | IBUPROFEN | Harris Teeter | 180557e4-335e-f520-e063-6394a90a2fa4 | 2024-08-20 | Warnings | WK2XYI10QM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.